For decades, poor treatment options and low-quality evidence plagued care for patients with rifampin-resistant tuberculosis. The advent of new drugs to treat tuberculosis and enhanced funding now ...
1 First Department of Infectious Diseases, The First Affiliated Hospital of China Medical University, Shenyang, China 2 Department of Infectious Diseases, The First Affiliated Hospital of Xiamen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback